Search
for
Sort by
Research 331–360 of 1000+
- Hidradenitis Suppurativa
- Stem cells and aberrant signaling of molecular systems in skin aging
- Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone
- Skin disease in pregnancy
- Alopecia Areata
- Group IID, IIE, IIF and III secreted phospholipase A2s
- Injectable “Skin Boosters” in Aging Skin Rejuvenation: A Current Overview
- Sterol Intermediates of Cholesterol Biosynthesis Inhibit Hair Growth and Trigger an Innate Immune Response in Cicatricial Alopecia
- ADVANCES IN PSORIASIS THERAPY
- The Use of Adipose-Derived Stem Cells in Selected Skin Diseases (Vitiligo, Alopecia, and Nonhealing Wounds)
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models
- A review on laser and light-based therapies for alopecia areata
- Gut microbiota in alopecia areata
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Non-Transfusional Hemocomponents: From Biology to the Clinic—A Literature Review
- Current Concepts and Translational Uses of Platelet Rich Plasma Biotechnology
- Spectrum of mucocutaneous manifestations in human immunodeficiency virus-infected patients and its correlation with CD4 lymphocyte count
- 25 years of ERβ: a personal journey
- The developing immune network in human prenatal skin
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- Regulatory Mechanisms of Natural Active Ingredients and Compounds on Keratinocytes and Fibroblasts in Mitigating Skin Photoaging
- Association of vitamin D level with alopecia areata
- New potential antiscarring approaches
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective